3,3'-[(1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino]bis(2,4,6-triiodobenzoic acid) - 1-deoxy-1-(methylamino)hexitol (1:2),39472-29-2 Products Supply

Name: 3,3'-[(1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino]bis(2,4,6-triiodobenzoic acid) - 1-deoxy-1-(methylamino)hexitol (1:2)
CAS NO.: 39472-29-2
Synonyms:
Cholovue;Endobil;IODOXAMATE MEGLUMINE;Meglumine iodoxamate;Methylglucamine iodoxamate;Iodoxamic acid meglumine salt;EINECS 257-398-6;Benzoic acid, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodo-, compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2);Bis(1-deoxy-1-(methylamino)-D-glucitol) 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodobenzoate);D-Glucitol, 1-deoxy-1-(methylamino)-, 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-diyl)diimino)bis(2,4,6-triiodobenzoate) (2:1) (salt);51764-33-1;UNII-CIX5G6J9R1;AC1L233I;Iodoxamate Meglumine [USAN:BAN];LS-71357;3,3'-(Ethylenebis(oxyethyleneoxyethylenecarbonylimino))bis(2,4,6-triiodobenzoic acid) compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2);3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid; 6-(methylamino)hexane-1,2,3,4,5-pentol;39472-29-2
Molecular Structure:
Molecular Formula: C₄₀H₆₀I₆N₄O₂₀

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 3,3'-[(1,16-dioxo-4,7,10,13-te; 3,3'-{oxybis[(1-oxoethane-2,1-; 1/C15H13NO/c1-2-16-14-6-4-3-5-; 3,3'-[(1,3-dioxopropane-1,3-di; 1/C11H9N5O/c1-17-6-2-3-8-9(4-6; 1/C13H9IO2/c15-13-11-8-4-5-9-1; 3,3'-{oxybis[(1-oxoethane-2,1-; 1/C13H19NO2/c1-9(15)6-7-10-8-1; 1/C14H15O3P/c15-18(16-11-13-7-; 1/C13H15NO2/c15-8-10-7-9-3-1-5; Benzoic acid,3,3'-[(1,16-dioxo; Benzoic acid,3,3'-[(1,16-dioxo; 1/C11H14N2O6/c1-17-7(14)4-12-2; 1/C14H9Br2O2P/c15-11-6-8-13(17; 1/C15H18O2/c1-11(16)6-7-12-4-3; 1/C15H22O2/c1-10(2)6-5-7-11(3); 1/C22H28O6/c1-23-17-11-21(27-5; 1/C12H10N4O3/c1-3-19-12(18)10-; 1/C14H16O4/c1-5-10-12-9(14(15); 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C12H11NO4/c1-6-10(15)7-3-4-1; 1-ethyl-7-methyl-4-oxo-1,4-dih; 1/C14H12NS/c1-2-6-12(7-3-1)10-; 3,3'-[(1,16-dioxo-4,7,10,13-te; 2-hydroxybenzoic acid - 1-deox; 1/C9H6ClF3N2O/c1-15-7-5(10)2-4; 1/C12H16BrIO2/c1-3-5-15-11-8-1; 1/C14H19NO2/c1-3-12-10-17-9-8-; 2-[(8'R,9'S,10'S,13'S,14'S)-13; 1/C15H18N2O/c18-15-12-7-3-2-6-;